Latest Breaking News On - Trial oversight committee - Page 4 : comparemela.com

Acurx Pharmaceuticals, Inc Reports Second Quarter 2023 Results and Provides Business Update

STATEN ISLAND, N.Y., Aug. 14, 2023 /PRNewswire/ Acurx Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial. -Today at 07:02 am- MarketScreener

United statesUrsula theuretzbacherRobertg shawahBob delucciaDavidp luciKevin gareySociety or healthcare epidemiology of americaTrial oversight committeeExchange commissionUniversity of houston college pharmacyPrnewswire acurx pharmaceuticals incEuropean congressDrug administrationLeiden university medical center hollandInfectious disease society of america bostonAcurx pharmaceuticals inc

Acurx Pharmaceuticals to Discuss Second Quarter 2023 Financial Results and Provide Business Update

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

United statesDavidp luciRobertg shawahTrial oversight committeeDrug administrationDiseases society of americaPrnewswire acurx pharmaceuticals incAcurx pharmaceuticals incSociety or healthcare epidemiology of americaAcurx pharmaceuticalsChief executive officerChief financial officerIbezapolstat phaseBile acidClinical practice guidelinesDiseases society

Acurx Pharmaceuticals, Inc Reports First Quarter 2023 Results and Provides Business Update

STATEN ISLAND, N.Y., May 12, 2023 /PRNewswire/ Acurx Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat. | May 12, 2023

United statesDavidp luciKevin gareyRobertg shawahUrsula theuretzbacherBob delucciaExchange commissionDrug administrationData monitoring committeeDiseases society of americaUniversity of houston college pharmacyPrnewswire acurx pharmaceuticals incLeiden university medical center hollandExchange commission on formSociety or healthcare epidemiology of americaEuropean congress

Acurx Pharmaceuticals to Discuss First Quarter 2023 Financial Results and Provide Business Update

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

United statesRobertg shawahDavidp luciAcurx pharmaceuticals incSociety or healthcare epidemiology of americaTrial oversight committeeDiseases society of americaDrug administrationPrnewswire acurx pharmaceuticals incAcurx pharmaceuticalsChief executive officerChief financial officerIbezapolstat phaseBile acidClinical practice guidelinesDiseases society

Acurx Pharmaceuticals to Discuss First Quarter 2023 Financial Results and Provide Business Update

Acurx Pharmaceuticals to Discuss First Quarter 2023 Financial Results and Provide Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobertg shawahDavidp luciAcurx pharmaceuticals incDrug administrationSociety or healthcare epidemiology of americaTrial oversight committeePrnewswire acurx pharmaceuticals incAcurx pharmaceuticalsDiseases society of americaChief executive officerChief financial officerIbezapolstat phaseBile acidClinical practice guidelinesDiseases society